Further prospective studies are warranted to ascertain a potential causal relationship between acquired GH resistance and cardiac wasting, and to explore related interventions to center-act or prevent cardiac wasting–associated cardiomyopathy in advanced cancer. Here, GH1 is linked to cancer.